Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.

Autor: Pichot, C. S.1, Hartig, S. M.2, Xia, L.3, Arvanitis, C.4, Monisvais, D.4, Lee, F. Y.5, Frost, J. A.1, Corey, S. J.4 s-corey@northwestern.edu
Zdroj: British Journal of Cancer. 7/7/2009, Vol. 101 Issue 1, p38-47. 10p. 5 Graphs.
Databáze: Academic Search Ultimate